Heart Drug Approvals on the Wane, Study Says

Drug Industry Daily
A A
Drugs to treat heart disease are taking a shrinking slice of the FDA approval pie, a Tufts University study says.

To View This Article:

Login

Subscribe To Drug Industry Daily